-
'Vande Mataram': Why is India's freedom song in spotlight?
-
Ukrainian fashion designer debuts art between air raids
-
Counterculture pop artist Peter Max dies at 88: US media
-
Gambian businesses struggle under prolonged blackouts
-
Asian Games chief defends 'functional' rooms after backlash
-
Fiji declares national HIV crisis
-
Leader's sister says only 'idiots' think N. Korea to give up nukes
-
Australia to cut migration to fix housing crisis: minister
-
World's water cycle becoming more unpredictable, UN warns
-
NASA scan discovers new, 'once in a century' Moon crater
-
Where the US-China tariff row stands ahead of White House summit
-
Most stocks rise as Fed hikes and indicates drive to curb inflation
-
Croc-habitat gets green light for 2032 Olympic rowing
-
US again denies Palestinian leader Abbas visa to attend UN assembly
-
Indonesia cash-for-photos scheme turns animal hunters into protectors
-
Lula says he will go to UN to tell Trump to 'stay out' of Brazil's elections
-
'Left-field' life: Briton becomes Thailand's top foreign monk
-
Messi heads Inter Miami to Campeones Cup triumph
-
India's transgender amendment leaves many in limbo
-
AI looms large ahead of Xi, Trump summit
-
Trump to host Xi amid pomp, low expectations
-
Smith still haunted by 'Sandpapergate' as he prepares for South Africa Tests
-
Harry set for UK public outings with security, royal status hazy
-
UK-Sudanese author pens book to give children 'African history of Africa'
-
NFL Chiefs' Kelce among investors bilked in Ponzi scheme
-
Boehly and Walter sell Chelsea stake to Clearlake Capital
-
Guardian Metal Resources PLC Announces Audited Financial Results for the Year Ended 30 June 2026
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 17
-
Trump threatens EU over 'hostile' Canada association plan
-
US House backs data center power cost bill amid midterm backlash
-
Argentine judge orders suspension of Falklands oil project
-
US Congress passes sweeping Russia sanctions bill
-
Carrick takes the blame as troubled Man Utd suffer League Cup misery
-
Barca hit Racing for seven as Atletico crush Osasuna
-
Barcelona hit seven in Racing Santander rout
-
US Fed raises rates to tackle 'too high' inflation, irking Trump
-
Amorim's Milan beaten by Benfica, Sunderland make dream European return
-
Man Utd misery mounts after League Cup collapse against Brighton
-
US stocks fall, dollar gains after Fed lifts interest rates
-
Turkey releases 106 protesters, jails more LGBTQ activists
-
Seahawks rule out Darnold for Sunday game at Arizona
-
US Fed raises rates to tackle 'too high' inflation in move sure to rile Trump
-
Mbappe explains Ceuta shirt stance after criticism
-
England were 'waiting for death' in World Cup semi-final defeat: Tuchel
-
Improving Atletico cruise to comfortable win over Osasuna
-
NFL star fined for displaying name of slain Palestinian girl
-
Candidate for UN chief calls for AI regulation akin to nuclear weapons
-
Witsel retires from internationals after 18-year Belgium career
-
O'Neill expects Celtic recovery after Old Firm misery
-
US Fed raises rates to battle inflation in move likely to rile Trump
NEW REPORT: How High Prescription Drug Prices Shape the Lives of Hispanic and Latino Families
WASHINGTON, D.C. / ACCESS Newswire / September 2, 2026 / Hispanic and Latino patients are delaying treatment, rationing medication, taking on debt, and traveling abroad to purchase prescription drugs because they cannot afford the high prices charged in the United States, according to a new report released today by Patients For Affordable Drugs, We Are Más, and Brown University's Information Futures Lab.
The Price Patients Pay: How Unaffordable Prescription Drugs Shape the Health, Finances, and Daily Lives of Hispanic and Latino Communitiesoffers a look beyond national statistics and examines the experiences of patients navigating the U.S. prescription drug affordability crisis. The report offers actionable recommendations for policymakers, healthcare providers, advocacy organizations, philanthropists, and community leaders to improve prescription drug affordability, hold those in power accountable, and help ensure patients can access the medications they need.

Read the full report in English here, and in Spanish here
"Prescription drug prices are high because the system in the U.S. allows drug companies to charge prices that are at least four times higher than what patients in other countries pay," said Merith Basey, CEO of Patients For Affordable Drugs. "Those prices adversely affect Hispanic and Latino communities at a higher rate, yet their experiences are too often absent from the conversations about the solutions. This report helps ensure their voices are included in the fight to make prescription drugs more affordable."
"Many of the people we spoke with know firsthand that the same medicines can be far more affordable in other countries. That perspective makes it very clear that these prices are not inevitable," said Evelyn Pèrez-Verdïa, CEO of the bilingual social impact agency, We Are Más. "Families are drawing on relatives, community networks, and connections across borders to get the medicines they need. But those networks should be a source of strength, not a substitute for an affordable healthcare system."
"A health system that can identify and procure the medicine that could keep someone well-or alive-and then make that medicine financially unreachable is failing at its most basic job," said Stefanie Friedhoff, Professor of the Practice and director of the Information Futures Lab at Brown University School of Public Health. "In a country with the resources of the United States, that is not only a health care problem; it is a public health failure. Too often the consequences are blamed on patients rather than the systems that produced them."
While polling shows that Hispanic and Latino communities are disproportionately burdened by high prescription drug prices, this report goes beyond the data to document the lived experiences of Hispanic, Latino, and Spanish-speaking adults in South Florida. Through five weeks of interviews, weekly questionnaires, and community discussions-most conducted in Spanish-it captures the difficult decisions families make when medicines become unaffordable, the emotional toll of those choices, and the strategies patients use to stay healthy.
While every participant's story was unique, several clear themes emerged throughout the project.
Patients are forced to choose between medicine and basic necessities. Participants regularly described deciding between filling prescriptions, buying groceries, paying rent, or covering utility bills, often at the expense of their health and financial stability.
"Just imagine not having the medication you need to survive...the sheer anguish of knowing that the medication exists, yet being unable to go get it, is horrible."
The consequences extend far beyond financial hardship. High prescription drug prices contributed to chronic stress, anxiety, social isolation, strained family relationships, and fear about losing access to lifesaving medications.
Patients view unaffordable prescription drugs as the result of systemic failures, not personal choices.
"Everyone here in the U.S. should have access to affordable medication - after all, I see that in other countries, many people enjoy that benefit."
Patients developed risky strategies to access lifesaving drugs. Participants reported rationing medications, delaying treatment, purchasing prescriptions abroad, relying on credit cards, searching extensively for lower-cost options, and turning to family and community networks when the healthcare system failed them.
Community networks are critical - but lasting solutions require systemic reform. While support from trusted healthcare providers, family members, and community organizations helped participants navigate the system, they consistently emphasized that lasting relief will require systemic reform.
"It often feels like the system makes it harder on purpose so patients end up paying full price"
Within the report, readers will also find additional patient stories, in-depth analysis of the project's key themes, and recommendations informed directly by participants' experiences.
Read the full report in English here, and in Spanish here.
###
Patients For Affordable Drugs is the only national patient advocacy organization focused exclusively on policies that lower prescription drug prices. We empower and mobilize patients by amplifying their experiences with high drug prices to hold those in power accountable and fight to shape and achieve system-changing policies that make prescription drugs affordable for all people in the United States. P4AD does not accept funding from organizations that profit from the development or distribution of drugs. To learn more, visit: PatientsForAffordableDrugs.org
We Are Más is a South Florida-based social impact organization specializing in culturally competent, hyperlocal engagement with diaspora groups in Hispanic, English- and Spanish-speaking communities. Working with a variety of purpose-driven organizations across the public, private, and third sectors, We Are Más combines listening and an active local presence with research and strategic communications to support partners in connecting deeply with communities in diverse places such as South Florida, Texas, and other Hispanic communities across the U.S.
Brown University's Information Futures Lab is a new type of university hub. Interdisciplinary researchers work alongside organizations, journalists, civic society leaders, and other sources of trusted information to respond to the information crisis as a civic and public health threat. Recognizing information as a social determinant of health, we create an evidence base and work with our partners to improve information ecosystems and strengthen the capacity of citizens to effectively access, create, and make sense of information that is crucial to their well-being. Learn more about the Information Futures Lab and its initiatives on our website.
CONTACT: Brennan Fiske [email protected]
SOURCE: Patients For Affordable Drugs
View the original press release on ACCESS Newswire
M.O.Allen--AT